Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area

Hurt Blocker

| James Strachan |

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions

Disease Area

Super Saliva Test

| William Aryitey |

Can an oral fluid assay for HIV be as sensitive as a blood test?

Disease Area

A Second Tour of Duty… Lessons Learned with Annalisa Jenkins

| James Strachan |

Annalisa explains how the military gave her an excellent platform to launch a high-level career in pharma.

Disease Area

Beating the Resistance

| William Aryitey |

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

Disease Area

Resisting Arrest

| Roisin McGuigan |

Could resonance Raman spectroscopy be the key to your heart?

Disease Area

Fostering Better care

| Michael Schubert |

Children entering foster care are receiving extensive screening – but is it cost-effective?

Disease Area

Pain and Vision Gain

| Roisin McGuigan |

An analgesic is helping researchers explore new drug targets for sight-threatening diseases

Disease Area

Dark Fields and Diagnostic Disks

| Michael Schubert |

New devices for detecting tuberculosis may speed up diagnosis and improve treatment

Disease Area

From MS to AMR

| Roisin McGuigan |

A drug used to treat MS could be repurposed to treat infections in cystic fibrosis patients

Disease Area

The Next (Air)Wave of Inhalables

| David Lewis |

For inhaler technology to evolve, questions about efficacy must be answered

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register